Literature DB >> 17761426

Distribution and cellular localization of adrenoleukodystrophy protein in human tissues: implications for X-linked adrenoleukodystrophy.

Romana Höftberger1, Markus Kunze, Isabelle Weinhofer, Fahmy Aboul-Enein, Till Voigtländer, Iris Oezen, Gabriele Amann, Hanno Bernheimer, Herbert Budka, Johannes Berger.   

Abstract

Defects of adrenoleukodystrophy protein (ALDP) lead to X-linked adrenoleukodystrophy (X-ALD), a disorder mainly affecting the nervous system white matter and the adrenal cortex. In the present study, we examine the expression of ALDP in various human tissues and cell lines by multiple-tissue RNA expression array analysis, Western blot analysis, and immunohistochemistry. ALDP-encoding mRNA is most abundant in tissues with high energy requirements such as heart, muscle, liver, and the renal and endocrine systems. ALDP selectively occurs in specific cell types of brain (hypothalamus and basal nucleus of Meynert), kidney (distal tubules), skin (eccrine gland, hair follicles, and fibroblasts), colon (ganglion cells and epithelium), adrenal gland (zona reticularis and fasciculata), and testis (Sertoli and Leydig cells). In pituitary gland, ALDP is confined to adrenocorticotropin-producing cells and is significantly reduced in individuals receiving long term cortisol treatment. This might indicate a functional link between ALDP and proopiomelanocortin-derived peptide hormones.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17761426     DOI: 10.1016/j.nbd.2007.07.007

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  13 in total

Review 1.  Current and future pharmacological treatment strategies in X-linked adrenoleukodystrophy.

Authors:  Johannes Berger; Aurora Pujol; Patrick Aubourg; Sonja Forss-Petter
Journal:  Brain Pathol       Date:  2010-07       Impact factor: 6.508

Review 2.  X-linked adrenoleukodystrophy: pathogenesis and treatment.

Authors:  Marc Engelen; Stephan Kemp; Bwee-Tien Poll-The
Journal:  Curr Neurol Neurosci Rep       Date:  2014-10       Impact factor: 5.081

Review 3.  Drug transporters, the blood-testis barrier, and spermatogenesis.

Authors:  Linlin Su; Dolores D Mruk; C Yan Cheng
Journal:  J Endocrinol       Date:  2010-12-06       Impact factor: 4.286

4.  Adenoassociated virus serotype 9-mediated gene therapy for x-linked adrenoleukodystrophy.

Authors:  Yi Gong; Dakai Mu; Shilpa Prabhakar; Ann Moser; Patricia Musolino; JiaQian Ren; Xandra O Breakefield; Casey A Maguire; Florian S Eichler
Journal:  Mol Ther       Date:  2015-01-16       Impact factor: 11.454

5.  Function of the tryptophan metabolite, L-kynurenine, in human corneal endothelial cells.

Authors:  Nermin Serbecic; Imad Lahdou; Alexander Scheuerle; Romana Höftberger; Fahmy Aboul-Enein
Journal:  Mol Vis       Date:  2009-07-08       Impact factor: 2.367

Review 6.  Adrenoleukodystrophy - neuroendocrine pathogenesis and redefinition of natural history.

Authors:  Stephan Kemp; Irene C Huffnagel; Gabor E Linthorst; Ronald J Wanders; Marc Engelen
Journal:  Nat Rev Endocrinol       Date:  2016-06-17       Impact factor: 43.330

Review 7.  Mammalian peroxisomal ABC transporters: from endogenous substrates to pathology and clinical significance.

Authors:  Stephan Kemp; Frederica L Theodoulou; Ronald J A Wanders
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

Review 8.  Pathophysiology of X-linked adrenoleukodystrophy.

Authors:  J Berger; S Forss-Petter; F S Eichler
Journal:  Biochimie       Date:  2013-12-04       Impact factor: 4.079

9.  The peroxisomal fatty acid transporter ABCD1/PMP-4 is required in the C. elegans hypodermis for axonal maintenance: A worm model for adrenoleukodystrophy.

Authors:  Andrea Coppa; Sanjib Guha; Stéphane Fourcade; Janani Parameswaran; Montserrat Ruiz; Ann B Moser; Agatha Schlüter; Michael P Murphy; Jose Miguel Lizcano; Antonio Miranda-Vizuete; Esther Dalfó; Aurora Pujol
Journal:  Free Radic Biol Med       Date:  2020-02-01       Impact factor: 7.376

Review 10.  Oxidative stress and adrenocortical insufficiency.

Authors:  R Prasad; J C Kowalczyk; E Meimaridou; H L Storr; L A Metherell
Journal:  J Endocrinol       Date:  2014-03-12       Impact factor: 4.286

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.